A Blue Ash-based medical device aims to use new capital to help get its products into surgeons’ hands.
On Tuesday, Standard Bariatrics announced it landed $35 million in Series B capital led by Silicon Valley-based U.S. Venture Partners, which specializes in early-stage ventures in enterprise software, cyber security, consumer, e-commerce, health care and IT-enabled health care services.
Standard Bariatrics is the maker of the Titan SGS, a stapling technology designed specifically for surgery related to obesity. The device received clearance from the U.S. Food and Drug Administration in April.
Click here to read the complete story.
Story excerpt provided by Cincy Inno.
Written by Meg Garner.
Originally published June 1, 2021.